Literature DB >> 22890733

Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective β-adrenergic blocker.

Chia-Chi Hsu, Julia Yu-Yun Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22890733     DOI： 10.1016/j.jaad.2012.04.017

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Botulinum toxin blocks mast cells and prevents rosacea like inflammation.

Authors:  Jae Eun Choi; Tyler Werbel; Zhenping Wang; Chia Chi Wu; Tony L Yaksh; Anna Di Nardo
Journal:  J Dermatol Sci       Date:  2018-12-28       Impact factor: 4.563

2.  [Systemic therapy of rosacea].

Authors:  M Schaller; K Belge
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751

Review 3.  [Pathogenesis, clinical picture, and current therapy of rosacea].

Authors:  L I Gonser; C E Gonser; M Schaller
Journal:  Hautarzt       Date:  2016-01       Impact factor: 0.751

4.  Carvedilol, an Adrenergic Blocker, Suppresses Melanin Synthesis by Inhibiting the cAMP/CREB Signaling Pathway in Human Melanocytes and Ex Vivo Human Skin Culture.

Authors:  Myoung Eun Choi; Hanju Yoo; Ha-Ri Lee; Ik Joon Moon; Woo Jin Lee; Youngsup Song; Sung Eun Chang
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 5.  Conventional and Novel Treatment Modalities in Rosacea.

Authors:  Burhan Engin; Defne Özkoca; Zekayi Kutlubay; Server Serdaroğlu
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.